| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Strategy &Corporate Dev | EVP Strategy And Corporate Dev | EVP Strategy &Corp Dev +3 more
1 company
Dolan Matthew Vincent is an EVP, Strategy &Corporate Dev at DEXCOM INC. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $2.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | DXCM Dexcom Inc | EVP, Strategy &Corporate Dev | Sell | 1,183 | $86.91 | $102,819.74 | -2.7% | -17.5% | -14.4% | |
| May 15, 2024 | DXCM Dexcom Inc | EVP Strategy And Corporate Dev | Sell | 2,423 | $126.58 | $306,703.34 | -5.7% | -45.2% | -34.0% | |
| Apr 15, 2024 | DXCM Dexcom Inc | EVP Strategy And Corporate Dev | Sell | 1,990 | $137.81 | $274,241.90 | -4.5% | -16.0% | -48.6% | |
| Mar 15, 2024 | DXCM Dexcom Inc | EVP Strategy &Corp Dev | Sell | 4,203 | $130.21 | $547,259.08 | -3.0% | -12.8% | -45.8% | |
| Mar 12, 2024 | DXCM Dexcom Inc | EVP Strategy And Corporate | Sell | 6,710 | $134.41 | $901,895.80 | -12.1% | -13.9% | -47.7% | |
| Sep 1, 2023 | DXCM Dexcom Inc | SVP Corporate Strategy-develop | Sell | 56 | $102.32 | $5,729.92 | -0.2% | +13.4% | -31.9% | |
| Mar 16, 2023 | DXCM Dexcom Inc | SVP Corporate Strategy-develop | Sell | 2,303 | $115.00 | $264,845.00 | -6.4% | +10.9% | +13.9% | |
| Mar 13, 2023 | DXCM Dexcom Inc | SVP Corporate Strategy-develop | Sell | 6,229 | $106.27 | $661,955.83 | -14.8% | +14.7% | +22.3% | |
| Mar 6, 2023 | DXCM Dexcom Inc | SVP Corporate Strategy-develop | Sell | 226 | $114.40 | $25,854.40 | -0.8% | +10.1% | +7.5% | |
| Sep 1, 2022 | DXCM Dexcom Inc | SVP Corporate Strategy-develop | Sell | 5 | $81.63 | $408.15 | - | +40.0% | +22.6% |